中国医药导报
   Apr. 5, 2025    Home                                                                                    中文
中国医药导报  2023, Vol. 20 Issue (31): 48-51    DOI: 10.20047/j.issn1673-7210.2023.31.09
Current Issue | Archive | Adv Search |
Research progress on the related mechanisms of Apelin-13 in cognitive dysfunction
SHI Limin LIU Haijun XU Ping▲
Department of Neurology, Affiliated Hospital of Zunyi Medical University, Guizhou Province, Zunyi 563000, China
Download: PDF (492 KB)   HTML (1 KB) 
Export: BibTeX | EndNote (RIS)      
Abstract  Apelin is a bioactive peptide and an endogenous ligand for the angiotensin Ⅱ type one receptor-related protein APJ. Its precursor can be cleaved into various active fragments by proteases, with Apelin-13 having the strongest affinity with APJ. Apelin-13 is widely present in the central nervous system and exerts neuroprotective effects by regulating cell apoptosis, autophagy, synaptic plasticity, neuroinflammation, and oxidative stress. Neurons play an important role in the development and maturation of the nervous system, and neuronal damage is closely related to cognitive dysfunction. Therefore, the neuroprotective effect mediated by Apelin-13 has great potential for improving cognitive impairment caused by various reasons. This article reviews the latest research progress of Apelin-13 in cognitive impairment, which is expected to provide new targets and strategies for the treatment of cognitive impairment.
Key wordsCognition      Apelin-13      Apoptosis      Autophagy      Neuroinflammation      Synaptic plasticity      Oxidative stress     
Service
E-mail this article
Add to my bookshelf
Add to citation manager
E-mail Alert
RSS
Articles by authors
SHI Limin LIU Haijun XU Ping▲
Cite this article:   
SHI Limin LIU Haijun XU Ping▲. Research progress on the related mechanisms of Apelin-13 in cognitive dysfunction[J]. 中国医药导报, 2023, 20(31): 48-51.
URL:  
https://www.yiyaodaobao.com.cn/EN/10.20047/j.issn1673-7210.2023.31.09     OR     https://www.yiyaodaobao.com.cn/EN/Y2023/V20/I31/48
Copyright © Editorial Board of 中国医药导报
Supported by:Beijing Magtech